In tumors, OSM and other members of the IL-6 cytokine family can exhibit indirect pro-tumorigenic effects affecting the tumor microenvironment and stromal cells and modulating inflammatory and immune responses [51]. The gene discussed is IL6; the disease is neoplasm.